Skip to main content

CARACTERIZACION DE LAS PLAQUETAS “EDUCADAS” EN UN ENTORNO INFLAMATORIO CRONICO PARA OPTIMIZAR LAS TERAPIAS INMUNOREGULADORAS CON PLAQUETAS

PI17/00072

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de Investigación en Salud
Call year 2017
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre IIB-SANT PAU. INSTITUTO DE INVESTIGACION HOSPITAL SANTA CRUZ Y SAN PABLO
Execution centre IIB-SANT PAU. INSTITUTO DE INVESTIGACION HOSPITAL SANTA CRUZ Y SAN PABLO

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Phenotypic and functional consequences of plt binding to monocytes and its association with clinical features in sle

  • Mariscal, Anaís|||0000-0003-1013-4793
  • Zamora, Carlos|||0000-0003-2962-678X
  • Magallares López, Berta|||0000-0002-4691-2342
  • Salman-Monte, Tarek Carlos|||0000-0002-4676-0174
  • Ortiz, M. Àngels|||0000-0002-1574-9861
  • Diaz-Torne, Cesar|||0000-0001-6275-7699
  • Castellvi, Ivan|||0000-0002-5410-5807
  • Corominas, Hèctor|||0000-0002-7738-6787
  • Vidal, Silvia|||0000-0002-3909-6682
Platelets (PLTs) can modulate the immune system through the release of soluble mediators or through interaction with immune cells. Monocytes are the main immune cells that bind with PLTs, and this interaction is increased in several inflammatory and autoimmune conditions, including systemic lupus erythematosus (SLE). Our aim was to characterize the phenotypic and functional consequences of PLT binding to monocytes in healthy donors (HD) and in SLE and to relate it to the pathogenesis of SLE. We analyzed the phenotypic and functional features of monocytes with non-activated and activated bound PLTs by flow cytometry. We observed that monocytes with bound PLTs and especially those with activated PLTs have an up-regulated HLA-DR, CD86, CD54, CD16 and CD64 expression. Monocytes with bound PLTs also have an increased capacity for phagocytosis, though not for efferocytosis. In addition, monocytes with bound PLTs have increased IL-10, but not TNF-α, secretion. The altered phenotypic and functional features are comparable in SLE and HD monocytes and in bound PLTs. However, the percentages of monocytes with bound PLTs are significantly higher in SLE patients and are associated with undetectable levels of anti-dsDNA antibodies and hematuria, and with normal C3 and albumin/creatinine levels. Our results suggest that PLTs have a modulatory influence on monocytes and that this effect may be highlighted by an increased binding of PLTs to monocytes in autoimmune conditions.
Dipòsit Digital de Documents de la UAB
Publication Artículo de revisión (ReviewArticle)

The Dual Role of Platelets in the Cardiovascular Risk of Chronic Inflammation

  • Zamora, Carlos|||0000-0003-2962-678X
  • Cantó, Elisabet|||0000-0002-1782-1855
  • Vidal, Silvia|||0000-0002-3909-6682
Patients with chronic inflammatory diseases often exhibit cardiovascular risk. This risk is associated with the systemic inflammation that persists in these patients, causing a sustained endothelial activation. Different mechanisms have been considered responsible for this systemic inflammation, among which activated platelets have been regarded as a major player. However, in recent years, the role of platelets has become controversial. Not only can this subcellular component release pro- and anti-inflammatory mediators, but it can also bind to different subsets of circulating lymphocytes, monocytes and neutrophils modulating their function in either direction. How platelets exert this dual role is not yet fully understood.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Increase of Circulating Monocyte-Platelet Conjugates in Rheumatoid Arthritis Responders to IL-6 Blockage

  • Mariscal, Anaís|||0000-0003-1013-4793
  • Zamora, Carlos|||0000-0003-2962-678X
  • Diaz-Torne, Cesar|||0000-0001-6275-7699
  • Ortiz, M. Àngels|||0000-0002-1574-9861
  • Agustín de Oro, Juan José de|||0000-0001-7702-1625
  • Reina, Delia
  • Estrada, Paula|||0000-0002-9827-5680
  • Moya, Patricia|||0000-0001-8339-5420
  • Corominas, Hèctor|||0000-0002-7738-6787
  • Vidal, Silvia|||0000-0002-3909-6682
Platelets (PLT) bind to a significant percentage of circulating monocytes and this im-munomodulatory interaction is increased in several inflammatory and autoimmune conditions. The therapeutic blockage of IL-6 with Tocilizumab (TCZ) alters PLT and the phenotype and function of monocytes in rheumatoid arthritis (RA). However, the relationship between monocyte-PLT conjugates (CD14+PLT+) and clinical and immunological variables and the regulation of this interaction by IL-6 blockage are still unknown. Here, we compared the presence of monocyte-PLT conjugates (CD14+PLT+) and membrane CD162 expression using flow cytometry, and, by ELISA, the markers of PLT activation (sCD62P and sCD40L) in healthy donors (HD) and patients with long-standing RA before TCZ (baseline). We found higher percentages and absolute counts of CD14+PLT+, and higher plasmatic levels of sCD62P and sCD40L but lower CD162 expression on monocytes from RA patients than those from HD. Additionally, the levels of CD14+PLT+ inversely correlated with inflammatory parameters. Interestingly, 95% of patients with lower percentages of CD14+PLT+ and only 63% of patients with higher percentages of CD14+PLT+ achieved a EULAR-defined response at four weeks (p = 0.036). After TCZ, the percentage of CD14+PLT+ increased in 92% of RA patients who achieved 12 w-remission (p < 0.001). Our results suggest that the binding of PLTs has a modulatory effect, accentuated by the increased binding of PLTs to monocytes in response to the therapeutic blockage of IL-6.